Lawrence Berkeley National Laboratory scientists have developed the world's first x-ray computed tomography (CT) scanner capable of examining entire core samples at remote drilling sites. The portable ...

Cooper University Health Care in Camden said it will begin offering a portable CT scanner for medically fragile and critically ill patients. Health officials at the South Jersey-based health care ...

MARS Bioimaging, a New Zealand–headquartered medical device company specialising in portable spectral photon-counting CT scanners for point-of-care diagnosis and clinical research, has closed an ...

Micro-X has completed construction of its first Head CT device, which weighs about 70kg and can be fitted to a standard ambulance. It’s about a tenth of the weight of a traditional CT device. Hospital ...

Christchurch medtech Mars Bioimaging has raised $15 million in a Series A round to take its portable CT scanner to the market. The Government’s new Golden Visa programme is credited with helping get ...

The Global CT Scanner Market is projected to reach USD 6.20 Billion by 2022, at a CAGR of 5.4% during the forecast period. Factors like growing need for effective and early diagnosis, rising global ...

The Korean Food and Drug Administration has approved the CereTom portable eight-slice CT scanner from Neurologica Corp. and Korean distribution partner Dong Kang Medical Systems Co. Ltd. Intended for ...

NeuroLogica Corp. reported it has received regulatory clearance to market its portable and cordless CT scanner throughout most of Europe. SEMKO AB in Sweden gave Danvers-based NeuroLogica a CE product ...

The "CT Scanner Market by Type (Stationary, Portable), Architecture (C-arm, O-arm), Technology (High, Mid, Low Slice, CBCT), Application (Human, Veterinary, Research), End User - Global Forecast to ...

SELBYVILLE, Del., Oct. 29, 2020 /PRNewswire/ -- According to latest report "CT Scanner Market by Architecture (O-arm, C-arm), Type (Portable, Stationary), Technology ...

The Global CT Scanner Market is projected to reach USD 6.20 Billion by 2022, at a CAGR of 5.4% during the forecast period. Factors like growing need for effective and early diagnosis, rising global ...